| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 07/14/2005 | WO2005063715A1 Polymorph of birb 796, a p38map kinase inhibitor |
| 07/14/2005 | WO2005063692A1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 07/14/2005 | WO2005063241A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 07/14/2005 | WO2005063020A1 Plant growth regulation |
| 07/14/2005 | WO2005049579A3 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
| 07/14/2005 | WO2005035514A3 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 07/14/2005 | WO2004098528A3 Pyrazole-amine compounds useful as kinase inhibitors |
| 07/14/2005 | US20050154230 Urea derivatives |
| 07/14/2005 | US20050154202 Substituted aryl amides |
| 07/14/2005 | US20050154056 Inhibitors of HCV NS5B polymerase |
| 07/14/2005 | US20050154011 such as S)-3-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester, used in the treatment of protein tyrosine phosphatase (PTPase) mediated disorder such as diabetes |
| 07/14/2005 | US20050153996 Compounds that modulate ppar activity and methods for their preparation |
| 07/14/2005 | US20050153988 Novel polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| 07/14/2005 | US20050153958 Substituted aryl ketones |
| 07/14/2005 | US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof |
| 07/14/2005 | US20050150764 3-Phenyl-4-(pyrazol-1-yl)-1-(4-substituted-phenylamino)carbonyl-1,4,5,6-tetrahydropyridazines; insecticides, arachnidicides, nematocides; plant protection agents; [specifications are a pesticide, but claims are the quantitative voltammetric determination of an ion in a fluid using a coated electrode] |
| 07/14/2005 | DE10360369A1 Amide Amides |
| 07/14/2005 | CA2550894A1 Plant growth regulation |
| 07/14/2005 | CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | CA2547837A1 Polymorph of birb 796, a p38map kinase inhibitor |
| 07/13/2005 | EP1553087A1 Preventive and/or therapeutic drugs for inflammatory intestinal diseases |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1553074A1 Fused benzene derivative and use |
| 07/13/2005 | EP1551809A1 Pyrazole compounds for treatment of neurodegenerative disorders |
| 07/13/2005 | EP1551799A1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 07/13/2005 | EP1551798A1 Novel sulphones for inhibition of gamma secretase |
| 07/13/2005 | EP1551511A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 07/13/2005 | EP1551403A1 5-substituted 2h-pyrazone-3-carboxylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia |
| 07/13/2005 | CN1639128A O-cyclopropyl-carboxanilides and their use as fungicides |
| 07/13/2005 | CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1638633A Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides |
| 07/13/2005 | CN1636991A Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636983A Substituted heterocyclic compounds |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/12/2005 | US6916957 Antiinflammatory agents; antihistamines; antiallergens |
| 07/12/2005 | US6916927 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction |
| 07/12/2005 | US6916924 Reacting an aromatic or heteroaromatic carbamate with a heteroarylamine compound to form an intermediate, coupling the intermediate with an electrophile in suitable base and a catalyst |
| 07/12/2005 | US6916839 4-ethynyl-1,5-dimethyl-3-(trifluoromethyl)-1H-pyrazolyl-3,5-bis(trifluoromethyl)benzene, used as insecticides and acaricides |
| 07/12/2005 | US6916838 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/12/2005 | US6916814 Methods of treating cytokine mediated diseases |
| 07/12/2005 | US6916813 (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase |
| 07/12/2005 | US6916798 Inhibitors of glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase; for treatment and prevention of diabetes and Alzheimer's disease |
| 07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | WO2005061464A1 Herbicidal heteroaroyl-substituted phenylalanine amides |
| 07/07/2005 | WO2005061463A1 Pyrazole derivatives as protein kinase modulators |
| 07/07/2005 | WO2005061462A2 Diaryl pyrazole derivatives and their use as neurokinin-3 receptor modulators |
| 07/07/2005 | WO2005061443A2 Benzoyl-substituted phenylalanine amides |
| 07/07/2005 | WO2005060959A1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 07/07/2005 | WO2005060749A1 Substituted arylpyrazoles as parasiticidal agents |
| 07/07/2005 | US20050148649 Substituted arylpyrazoles |
| 07/07/2005 | US20050148648 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators |
| 07/07/2005 | US20050148623 HIV protease inhibiting compounds |
| 07/07/2005 | US20050148605 Modulation of protein tyrosine kinases for treatment of diseases with prodrugs |
| 07/07/2005 | US20050147633 Insecticidal amides with nitrogen-containing benzo-Fused bicyclic ring systems |
| 07/07/2005 | DE10356579A1 Aminderivate Amine derivatives |
| 07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | CA2548442A1 Benzoyl-substituted phenylalanine amides |
| 07/07/2005 | CA2548374A1 Pyrazole derivatives as protein kinase modulators |
| 07/07/2005 | CA2548354A1 Herbicidal heteroaroyl-substituted phenylalanine amides |
| 07/06/2005 | EP1550668A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 07/06/2005 | EP1550656A1 4-5-diamino-n,n-dihydro-pyrazol-3-one derivatives for use in composition for dyeing keratin fibres |
| 07/06/2005 | EP1550461A1 Remedy for chronic disease |
| 07/06/2005 | EP1550370A1 Plant growth regulation |
| 07/06/2005 | EP1549620A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors |
| 07/06/2005 | EP1549619A1 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 07/06/2005 | EP1549618A1 Pyrazolone compounds as thrombopoietin receptor activators |
| 07/06/2005 | EP1549613A1 Sulfonamides having antiangiogenic and anticancer activity |
| 07/06/2005 | EP1549283A1 Merocyanine derivatives for cosmetic use |
| 07/06/2005 | EP1549143A2 Antibacterial pyrazole carboxylic acid hydrazides |
| 07/06/2005 | CN1635979A IL-8 receptor antagonists |
| 07/05/2005 | US6914069 Pharmaceutically active compounds and methods of use |
| 07/05/2005 | CA2208742C Monoazo pigments |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058868A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/30/2005 | WO2005058839A1 Optically active carboxamides and use thereof to combat undesirable microorganisms |
| 06/30/2005 | WO2005058838A1 Pyrazolinols used as pesticides |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | WO2005016277A3 Arylsulfonamidobenzylic compounds |
| 06/30/2005 | WO2004085388A3 Cyclic protein tyrosine kinase inhibitors |
| 06/30/2005 | US20050143443 4-substituted pyrrole-2-carboxylic acidsand 5-substituted pyrazole-3-carboxylic acids/esters/salts; increase D-Serine level; reduce level of toxic products of D-Serine oxidation; activate N-methyl-D-aspartate NMDA-glutamate receptors; neuropathic agent, schizophrenia, Alzheimer's, anaxia |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/30/2005 | US20050143380 Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof |
| 06/30/2005 | US20050143355 Pharmaceutically active salts and esters of 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol and 3- (3-dimethylamino-1-ethyl-1-hydroxy-2-methylpropyl)-phenol and methods of using same |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | DE10354584A1 Kationische Diaminopyrazole, ein Verfahren zu deren Herstellung und diese Verbindungen enthaltende Färbemittel Cationic diaminopyrazoles, a process for their preparation and compositions containing these compounds colorant |
| 06/30/2005 | CA2557004A1 Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
| 06/30/2005 | CA2549825A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/30/2005 | CA2549821A1 Optically active carboxamides and use thereof to combat undesirable microorganisms |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/29/2005 | EP1546132A1 Pyrazole derivatives as reverse transcriptase inhibitors |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | CN1633412A Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |